4.2 Read 124 reviews
Featured byUCL
Overview
Key facts
University College London (UCL)'s Cell and Gene Therapy Bioprocessing (MBI Training, Bioprocess Industries) four-day online course addresses the challenges of translating scientific discoveries into medicinal products in a way that's commercially viable.
It's aimed at engineers, life scientists and clinicians working in regenerative medicine and cell and gene therapy.Programme Structure
Courses include:
- Challenges for scaling up lentivirus
- Taking cell and gene products from lab to clinic in the real world
- Process considerations for universal versus personalised therapies
- Analytics and monitoring where the cell is the product
- A role for automation
- Navigating the critical path to clinic
- Addressing process economics and CoGs
Key information
Duration
- Part-time
- 4 days
Start dates & application deadlines
You can apply for and start this programme anytime.
Language
English
Delivered
Online
Disciplines
Biology Molecular SciencesAcademic requirements
We are not aware of any specific GRE, GMAT or GPA grading score requirements for this programme.
English requirements
We are not aware of any English requirements for this programme.
Other requirements
General requirements
- This course is for engineers, life scientists and clinicians working in the fields of regenerative medicine and cell and gene therapy.
- It also provides a strong fundamental base for life scientists and engineers from biopharma who wish to re-purpose skills for the cell and gene therapy sector.
Tuition Fee
To always see correct tuition fees
-
International
1750 GBP/fullTuition FeeBased on the tuition of 1750 GBP for the full programme during 4 days. -
National
1750 GBP/fullTuition FeeBased on the tuition of 1750 GBP for the full programme during 4 days.
Funding
Improve page content